Top Stories
No archived items in this category yet.
Top Headlines
STAT+: FDA to speed up review of three psychedelics as mental health treatments
Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.
STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts has some answers.
STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment
A Utah pilot to renew prescriptions using a bot faced backlash from the state's medical board, which called for an immediate suspension.
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Lawmakers introduce bipartisan legislation to improve access, quality of care in Medicare Advantage plans
The Medicare Advantage Improvement Act of 2026, introduced April 20, aims to “directly address” barriers to coverage and treatment for America’s seniors.
HCA Healthcare executives shrug off Q1 volumes disruptions, reaffirm FY2026 guidance
A sharp end to the flu season and disruptive winter storms dragged the country's largest for-profit health system in January. Executives said there's already signs of recovery since the stumble and pointed to favorable…
International childhood vaccine campaign grows
In today's Morning Rounds newsletter, a new era in GOP drug policy, an international childhood vaccine campaign grows, and more.
STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more
President Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White House
STAT+: Sanofi MS drug gets positive review in Europe following FDA
A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.
UnitedHealthcare, Aetna, Cigna tout progress to standardize prior authorization as part of industry-wide commitment
Major health insurers are advancing efforts to standardize prior authorization requirements as part of an effort to simplify paperwork for providers and reduce delays in medical care.
Industry Voices—Hospitals are very online, but what happens when they're plunged into 'digital darkness'?
Healthcare organizations have a responsibility to prepare their people and their systems for the analog reality that a cyberattack, an outage or a cascading infrastructure failure can impose at any moment, writes ECRI P…
Psychedelics get a boost from the White House
In this week’s STATus Report, host Alex Hogan chats with STAT Washington correspondent Daniel Payne about Trump's psychedelics EO.